Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Baulieu, E.-E.
Right arrow Articles by Hajri, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baulieu, E.-E.
Right arrow Articles by Hajri, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 10, 2243-2244, October 2001
© 2001 European Society of Human Reproduction and Embryology


Letters to the Editor

Mifepristone (RU486) and voluntary termination of pregnancy: enigmatic variations* or anecdotal religion-based attitudes?

Etienne-Emile Baulieu1,1, Daniel S. Seidman2 and Selma Hajri3

1 Inserm and Collège de France, Pincus Building, 80 rue du Général Leclerc 94276 Le Kremlin-Bicêtre, France 2 Department of Obstetrics and Gynecology, Chaim Sheba Medical Center 52621 Tel-Hashomer, Israel 3 1, rue de la Mosquée, Marsa Plage 2070 Tunis, Tunisia

Dear Sir,

Mifepristone (RU486), the first clinically efficient antiprogesterone (Herrmann et al., 1982Go; Baulieu, 1989Go), has made the concept of medical abortion a reality (Ulmann et al., 1992Go). Here we only refer to the voluntary termination of early pregnancy, which sustains so much controversy in the vast and evolving domain of women's reproductive health (Van Look, 2000Go). Legally on the market for years in France, Britain and Sweden and massively produced and used in China, the compound has become available to women in need in . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?